Lite Strategy, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Lite Strategy, Inc. (LITS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $25.64 per share for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2025-09-26
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-09-30 was $21.85, a 39.89% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-09-30 was $36.35, a 1494.30% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2022-09-30 was $2.28, a 26.45% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2021-09-30 was $3.10, a 10.40% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $25.64, a 33.12% decline from fiscal 2024.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $38.34, a 7.82% increase from fiscal 2023.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $35.56, a 1028.89% increase from fiscal 2022.
- Lite Strategy, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $3.15, a 8.16% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $25.64 10-K · filed 2025-09-26 | ||||
| 2024-12-31 | $25.14 10-Q · filed 2025-02-12 | ||||
| 2024-09-30 | $21.85 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $38.34 10-K · filed 2024-09-19 | ||||
| 2023-12-31 | $40.28 10-Q · filed 2024-05-09 | $38.32 10-Q · filed 2024-02-13 | |||
| 2023-09-30 | $36.35 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $35.56 10-K · filed 2023-09-26 | ||||
| 2023-03-31 | $40.37 10-Q · filed 2023-05-11 | ||||
| 2022-12-31 | $2.05 10-Q · filed 2023-02-09 | ||||
| 2022-09-30 | $2.28 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $3.15 10-K · filed 2022-09-08 | ||||
| 2022-03-31 | $3.15 10-Q · filed 2022-05-23 | ||||
| 2021-12-31 | $3.13 10-Q/A · filed 2022-05-23 | ||||
| 2021-09-30 | $3.10 10-Q/A · filed 2022-05-23 | ||||
| 2021-06-30 | $3.43 10-K/A · filed 2022-05-23 | ||||
| 2021-03-31 | $3.65 10-Q · filed 2021-05-06 | ||||
| 2020-12-31 | $3.53 10-Q · filed 2021-02-04 | ||||
| 2020-09-30 | $3.46 10-Q · filed 2020-11-10 | ||||
| 2020-06-30 | $2.45 10-K · filed 2020-09-09 | ||||
| 2020-03-31 | $2.04 10-Q · filed 2020-05-07 | ||||
| 2019-12-31 | $2.04 10-Q · filed 2020-02-06 | ||||
| 2019-09-30 | $1.81 10-Q · filed 2019-11-07 | ||||
| 2019-06-30 | $3.10 10-K · filed 2019-08-28 | ||||
| 2019-03-31 | $3.16 10-Q · filed 2019-05-09 | ||||
| 2018-12-31 | $3.15 10-Q · filed 2019-02-07 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | ||||
| 2018-06-30 | $3.44 10-K · filed 2018-08-30 | ||||
| 2018-03-31 | $3.44 10-Q · filed 2018-05-09 | ||||
| 2017-12-31 | $2.44 10-Q · filed 2018-02-08 | ||||
| 2017-09-30 | $2.45 10-Q · filed 2017-11-08 | ||||
| 2017-06-30 | $1.76 10-K · filed 2017-09-05 | ||||
| 2017-03-31 | $1.36 10-Q · filed 2017-05-04 | ||||
| 2016-12-31 | $1.36 10-Q · filed 2017-02-08 | ||||
| 2016-09-30 | $1.36 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | $4.44 10-K · filed 2016-09-06 | ||||
| 2016-03-31 | $5.10 10-Q · filed 2016-05-05 | ||||
| 2015-12-31 | $6.90 10-Q · filed 2016-02-05 | ||||
| 2015-09-30 | $6.55 10-Q · filed 2015-11-06 | ||||
| 2015-06-30 | $6.89 10-K · filed 2015-09-02 | ||||
| 2015-03-31 | $7.10 10-Q · filed 2015-05-07 | ||||
| 2014-12-31 | $7.07 10-Q · filed 2015-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |